McDermott and Bull executive Search
 

Other News

Windtree Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Key Business Updates

WARRINGTON, Pa., April 2, 2020 /PRNewswire/ — Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today reported financial results for the fourth quarter ended December 31, 2019 and provided key business updates. Key Business and Financial […]

Artio Medical Closes $8.8 Million of Additional Financing

FAIRWAY, Kan., March 31, 2020 /PRNewswire/ — Artio Medical, Inc. (Artio), a medical device company developing innovative products for the peripheral vascular and neurovascular markets, announced today it has closed an additional $8.8 million in Series A financing, bringing the total capital raised to date to more than $20 million. “Artio is developing a strong […]

Former J&J/Biosense Webster Exec, Roy Tanaka, Joins S4 Medical’s Board of Directors

CLEVELAND, March 31, 2020 /PRNewswire/ — S4 Medical, an innovative medical device company focused on protecting the esophagus from damage during catheter ablation procedures, announced that Roy Tanaka has joined its board of directors, rounding out an impressive team. S4 Medical has developed a novel catheter called the “esolution” that utilizes a proprietary approach to […]

MediLynx Cardiac Monitoring, LLC introduces dedicated remote monitoring services based on its PocketECG® platform to support hospitals in managing COVID-19 patients in accordance with the latest FDA enforcement policy

PocketECG, MediLynx’s FDA approved remote monitoring systems: PocketECG Unified Arrhythmia Diagnostic System will be used for continuous streaming and analysis of full-disclosure ECG data, oxygen saturation, resting heart rate, patient symptoms and arrhythmia. The device is cleared by the FDA for the use of its data to analyze, measure and […]

Windtree Enters into Agreement with Lee’s Pharmaceutical for Non-Dilutive Funding of the Continued Development of AEROSURF®

WARRINGTON, Pa., March 31, 2020 /PRNewswire/ — Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, announces it has entered into a binding term sheet (the “Term Sheet”) with Lee’s Pharmaceutical Holdings (HK) Ltd (“Lee’s”) […]

Shimadzu Medical Systems USA completes integration of CORE Medical Imaging Inc. to strengthen healthcare business organization in North America

TORRANCE, Calif., April 1, 2020 /PRNewswire/ — Shimadzu Medical Systems USA (hereinafter “SMS”), completes the integration of Core Medical Imaging Inc. (hereinafter “CMI”), a subsidiary of SMS into the company. CMI is starting its new operation under the name of SMS Northwest branch, located in Kenmore, WA and will continue to provide best-in-class healthcare solutions and service […]

Heart Health Intelligence Raises Funds for a Revolutionary In-Home Cardiovascular Monitoring Device

Company Closes its $2.2M Seed Round to Support Commercialization of The Heart Seat™ ROCHESTER, N.Y., April 01, 2020 (GLOBE NEWSWIRE) — Given the current COVID-19 pandemic, the ability to monitor cardiovascular health in the home has become critical to reduce the burden on healthcare systems around the world. According to […]

BIOCARDIA ANNOUNCES POSITIVE DSMB RECOMMENDATION TO CONTINUE PHASE III PIVOTAL CARDIAMP HEART FAILURE STUDY, AS PLANNED

Company to Host Conference Call with National Co-Principal Investigators Today at 4:15 p.m. ET to Provide Study Updates SAN CARLOS, Calif., March 31, 2020 (GLOBE NEWSWIRE) — BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the independent Data Safety Monitoring Board (DSMB) […]

Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June

LAVAL, Québec, April 01, 2020 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and   commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today announced that it has filed […]